Immunoarchitectural patterns in follicular lymphoma: efficacy of HGAL and LMO2 in the detection of the interfollicular and diffuse components.
Am. J. Surg. Pathol., Sep;34(9):1266-76 (2010)
Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes.
Mod. Pathol., Mar;23(3):420-33 (2010)
C-C chemokine receptor 1 expression in human hematolymphoid neoplasia.
Am. J. Clin. Pathol., Mar;133(3):473-83 (2010)
Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: comparison with CD57 and lymphomas in the differential diagnosis.
Hum. Pathol., Dec;41(12):1726-34 (2010)
The efficacy of HGAL and LMO2 in the separation of lymphomas derived from small B cells in nodal and extranodal sites, including the bone marrow.
Am. J. Clin. Pathol., May;135(5):697-708 (2011)
Aggressive EBV-associated lymphoproliferative disorder: a prodrome to diffuse large B-cell lymphoma?
Appl. Immunohistochem. Mol. Morphol., May;20(3):325-30 (2012)
IgG4-related systemic sclerosing disease of the ocular adnexa: a potential mimic of ocular lymphoma.
Am. J. Clin. Pathol., May;137(5):699-711 (2012)
CD81 protein is expressed at high levels in normal germinal center B cells and in subtypes of human lymphomas.
Hum. Pathol., Feb;41(2):271-80 (2010)
Mast cell tryptase and microphthalmia transcription factor effectively discriminate cutaneous mast cell disease from myeloid leukemia cutis.
J. Cutan. Pathol., Apr;34(4):289-95 (2007)
Microvessel density and expression of vascular endothelial growth factor and its receptors in diffuse large B-cell lymphoma subtypes.
Am. J. Pathol., Apr;170(4):1362-9 (2007)
The utility of PAX5 immunohistochemistry in the diagnosis of undifferentiated malignant neoplasms.
Mod. Pathol., Aug;20(8):871-7 (2007)
Tissue microarrays from bone marrow aspirates for high-throughput assessment of immunohistologic markers in pediatric acute leukemia.
Pediatr. Dev. Pathol., 11(4):283-90 (2008)
Prognostic significance of VEGF, VEGF receptors, and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy.
Lab. Invest., Jan;88(1):38-47 (2008)
The biology of the germinal center.
Hematology Am Soc Hematol Educ Program., 210-5 (2007)
Immunohistochemical characterization of nasal-type extranodal NK/T-cell lymphoma using a tissue microarray: an analysis of 84 cases.
Am. J. Clin. Pathol., Sep;130(3):343-51 (2008)
Low stage follicular lymphoma: biologic and clinical characterization according to nodal or extranodal primary origin.
Am. J. Surg. Pathol., Apr;33(4):591-8 (2009)
The transcription factor LMO2 is a robust marker of vascular endothelium and vascular neoplasms and selected other entities.
Am. J. Clin. Pathol., Feb;131(2):264-78 (2009)
Lack of utility of CD20 immunohistochemistry in staging bone marrow biopsies for diffuse large B-cell lymphoma.
Appl. Immunohistochem. Mol. Morphol., Mar;17(2):93-5 (2009)
Lymphoma cell VEGFR2 expression detected by immunohistochemistry predicts poor overall survival in diffuse large B cell lymphoma treated with immunochemotherapy (R-CHOP).
Br. J. Haematol., Jan;148(2):235-44 (2010)
Immunoarchitectural patterns in nodal marginal zone B-cell lymphoma: a study of 51 cases.
Am. J. Clin. Pathol., Jul;132(1):39-49 (2009)
Immunophenotypic and genotypic characterization of progression in follicular lymphomas.
Appl. Immunohistochem. Mol. Morphol., Jun;12(2):97-104 (2004)
Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation.
Blood., May;105(10):3979-86 (2005)
Expression of CD163 (hemoglobin scavenger receptor) in normal tissues, lymphomas, carcinomas, and sarcomas is largely restricted to the monocyte/macrophage lineage.
Am. J. Surg. Pathol., May;29(5):617-24 (2005)
A novel method for making "tissue" microarrays from small numbers of suspension cells.
Appl. Immunohistochem. Mol. Morphol., Mar;13(1):80-4 (2005)
Cytologic diagnosis of Burkitt lymphoma.
Cancer., Oct;105(5):310-8 (2005)
Follicular dendritic cell immunohistochemical markers in angioimmunoblastic T-cell lymphoma.
Appl. Immunohistochem. Mol. Morphol., Dec;13(4):297-303 (2005)
Utility of syndecan-1 (CD138) expression in the diagnosis of undifferentiated malignant neoplasms: a tissue microarray study of 1,754 cases.
Appl. Immunohistochem. Mol. Morphol., Dec;13(4):304-10 (2005)
Prognostic immunohistologic markers in human tumors: why are so few used in clinical practice?
Lab. Invest., Aug;86(8):742-7 (2006)
EBV can protect latently infected B cell lymphomas from death receptor-induced apoptosis.
J. Immunol., Sep;177(5):3283-93 (2006)
Apoptosis stimulating protein of p53 (ASPP2) expression differs in diffuse large B-cell and follicular center lymphoma: correlation with clinical outcome.
Leuk. Lymphoma., Dec;43(12):2309-17 (2002)
Expression of the B-cell proliferation marker MUM1 by melanocytic lesions and comparison with S100, gp100 (HMB45), and MelanA.
Mod. Pathol., Aug;16(8):802-10 (2003)
Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation.
Am. J. Surg. Pathol., Oct;27(10):1346-56 (2003)
Large atypical cells of lymphomatoid papulosis are CD56-negative: a study of 18 cases.
J. Cutan. Pathol., Feb;29(2):88-92 (2002)
Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial.
Blood., Jun;101(11):4285-9 (2003)
The usefulness of immunohistochemistry in the diagnosis of follicular lymphoma in bone marrow biopsy specimens.
Am. J. Clin. Pathol., Apr;117(4):636-43 (2002)
Usefulness of HGAL and LMO2 Immunohistochemistry in the Identification of Follicular Lymphomas of the Non-Gastric Gastrointestinal Tract.
Appl. Immunohistochem. Mol. Morphol., Aug (2012)
Building "tissue" microarrays from suspension cells.
Methods Mol. Biol., 664:93-101 (2010)
HGAL protein expression persists in disorders of germinal center dissolution: potential role of HGAL in the germinal center microenvironment.
Appl. Immunohistochem. Mol. Morphol., May;19(3):266-72 (2011)
Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment.
Blood., Aug;118(5):1350-8 (2011)
Selective Immunophenotyping for Diagnosis of B-cell Neoplasms: Immunohistochemistry and Flow Cytometry Strategies and Results.
LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab.
J. Clin. Oncol., Jan;26(3):447-54 (2008)
Oncogenic regulators and substrates of the anaphase promoting complex/cyclosome are frequently overexpressed in malignant tumors.
Am. J. Pathol., May;170(5):1793-805 (2007)
Characterization of c-Maf transcription factor in normal and neoplastic hematolymphoid tissue and its relevance in plasma cell neoplasia.
Am. J. Clin. Pathol., Sep;132(3):361-71 (2009)
Microtubule-associated protein-2 is a sensitive marker of primary and metastatic neuroblastoma.
Am. J. Surg. Pathol., Nov;33(11):1695-704 (2009)
Expression of the bcl-6 and MUM1/IRF4 proteins correlate with overall and disease-specific survival in patients with primary cutaneous large B-cell lymphoma: a tissue microarray study.
J. Cutan. Pathol., Mar;32(3):227-34 (2005)
CD10 expression in peripheral T-cell lymphomas complicated by a proliferation of large B-cells.
Mod. Pathol., Mar;19(3):337-43 (2006)
Expression of the human germinal center-associated lymphoma (HGAL) protein identifies a subset of classic Hodgkin lymphoma of germinal center derivation and improved survival.
Blood., Jan;109(1):298-305 (2007)
The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas.
Blood., Feb;109(4):1636-42 (2007)
Expression of the RNA-binding protein VICKZ in normal hematopoietic tissues and neoplasms.
Haematologica., Feb;92(2):176-83 (2007)